https://charts.traderzeitung.de/phases/CA98420N1050 string(1460) "{"isin":"CA98420N1050","name":"Xenon Pharmaceuticals Inc","stock_id_xnas":7872879,"stock_id_xnys":null,"generated_at":"2026-08-09 08:05:00","days":[{"date":"2026-08-05","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":null,"close_at":null,"complete":true,"perf_pct":null},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":64.29,"close_at":"2026-08-05 21:59:00","complete":true,"perf_pct":null},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":64.5,"close_at":"2026-08-06 00:39:00","complete":true,"perf_pct":0.3266}]},{"date":"2026-08-06","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":64.3,"close_at":"2026-08-06 15:29:00","complete":true,"perf_pct":-0.3101},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":64.5,"close_at":"2026-08-06 21:59:00","complete":true,"perf_pct":0.311},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]},{"date":"2026-08-07","dst_offset":6,"phases":[{"phase":1,"label":"pre","from":"10:00","to":"15:30","close":64.06,"close_at":"2026-08-07 15:28:00","complete":true,"perf_pct":-0.6822},{"phase":2,"label":"regular","from":"15:30","to":"22:00","close":63.38,"close_at":"2026-08-07 21:59:00","complete":true,"perf_pct":-1.0615},{"phase":3,"label":"post","from":"22:00","to":"26:00","close":null,"close_at":null,"complete":true,"perf_pct":null}]}]}"

Xenon Pharmaceuticals Aktie News & Nachrichten

[WKN: A12ETN | Symbol: XENE]

Realtimekurs

Vorbörsliche Indikationen

Regulärer Handel

Nachbörslicher Handel

10J

Alles

Artikel aus der Redaktion der Trader-Zeitung

09.03.2026 um 16 Uhr

Xenon Pharmaceuticals

Stocks in Action USA: Vertiv, Xenon Pharmaceuticals, Hims & Hers Health

Vertiv (VRT) - KI-Boom treibt Indexaufstieg: Vier neue Unternehmen steigen in den S&P 500 auf! ...

Xenon Pharmaceuticals Nachrichtenticker öffnen

MT Newswires 07.08.2026 20:03 Uhr

Earnings Flash (XENE): Xenon meldet Q2 Verlust je Aktie von 1,11 USD, verglichen mit FactSet-Schätzung von 1,14 USD Verlust

MT Newswires 06.08.2026 22:22 Uhr

Xenon Pharmaceuticals Aktie News & Nachrichten

Artikel aus der Redaktion der Trader-Zeitung

Stocks in Action USA: Vertiv, Xenon Pharmaceuticals, Hims & Hers Health

Xenon Pharmaceuticals: Azetukalner-NDA-Einreichung nach FDA-Treffen laut RBC im Zeitplan

Wedbush passt Kursziel für Xenon Pharmaceuticals von $63 auf $71 an, hält am Outperform-Rating fest

--RBC passt Kursziel für Xenon Pharmaceuticals von 82 $ auf 81 $ an, behält Rating Outperform Speculative Risk bei

Xenon Pharmaceuticals verzeichnet höheren Q2-Verlust

Earnings Flash (XENE): Xenon meldet Q2 Verlust je Aktie von 1,11 USD, verglichen mit FactSet-Schätzung von 1,14 USD Verlust

-- Earnings Flash (XENE) Xenon Pharmaceuticals Inc. Meldet Q2-Umsatz $0